Roster Includes Pro-Bowl, All-Pro Athletes in Competition benefiting Coast Guard Foundation DALLAS, April 20, 2024 /PRNewswire/ — Sport Fishing Championship’s (SFC) The Catch, Powered by Verizon, with its star-studded roster of participants, is underway. The day-long competition pairs…
Month: April 2024
Más de 1,100 estudiantes se sumergen en la exploración de la IA, junto con educadores líderes, expertos de la industria, líderes gubernamentales y defensores de la comunidad SAN JOSÉ, California, 20 de abril de 2024 /PRNewswire-HISPANIC PR WIRE/ — En una colaboración innovadora, The Tech…
Más de 1,100 estudiantes se sumergen en la exploración de la IA, junto con educadores líderes, expertos de la industria, líderes gubernamentales y defensores de la comunidad SAN JOSÉ, California, 20 de abril de 2024 /PRNewswire-HISPANIC PR WIRE/ — En una colaboración innovadora, The Tech…
Más de 1,100 estudiantes se sumergen en la exploración de la IA, junto con educadores líderes, expertos de la industria, líderes gubernamentales y defensores de la comunidad SAN JOSÉ, California, 20 de abril de 2024 /PRNewswire-HISPANIC PR WIRE/ — En una colaboración innovadora, The Tech…
NEW YORK, April 20, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, April 20, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, April 20, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, April 20, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Akero Therapeutics, Inc. (“Akero” or the “Company”) (NASDAQ: AKRO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, April 20, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Akero Therapeutics, Inc. (“Akero” or the “Company”) (NASDAQ: AKRO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, April 20, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Akero Therapeutics, Inc. (“Akero” or the “Company”) (NASDAQ: AKRO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…